Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors
- PMID: 8018215
Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors
Abstract
We discovered substituted pyrazinones as a new class of allosteric modulators of gamma-aminobutyric acid (GABA)A receptors. Prototype pyrazinones, U-92813 [1-(furfuryl)-3,5-dichloro-6-phenylpyrazinone] and U-94863 [1-benzyl-3,5-dichloro-6-(2-chlorophenyl)pyrazinone], potentiated GABA-mediated Cl- currents in cloned GABAA receptors with certain subtype selectivity. The drugs markedly enhanced the GABA response in the alpha 1 beta 2 gamma 2 and alpha 1 beta 2 subtypes but not in the alpha 1 gamma 2 and beta 2 gamma 2 subtypes expressed in human kidney cells. The dose-response profile of U-94863 in the alpha 1 beta 2 subtype was largely indistinguishable from that in the alpha 1 beta 2 gamma 2 subtype, suggesting no critical role for the gamma 2 subunit in potentiation of the GABA response by the pyrazinones. The drugs also potentiated the GABA response in the alpha 3 beta 2 gamma 2 and alpha 6 beta 2 gamma 2 subtypes, indicating their nonselectivity toward the alpha isotypes. With respect to subtype selectivity, the pyrazinones differ not only from ligands for benzodiazepine receptors, which interact only with the subtypes containing alpha beta gamma subunits, but also from barbiturates and neurosteroids, which interact with all the subtypes tested in this study. The unique binding site for U-92813 on GABAA receptors was confirmed by the insensitivity of its action to Ro 15-1788, a classical benzodiazepine antagonist, and by the additive nature of its agonistic activity with that of barbiturates and neurosteroids. With respect to the mechanism of potentiation, the pyrazinones are similar to the other allosteric modulators, in that they potentiate the GABA response more effectively at low GABA concentrations than at high GABA concentrations. We propose that substituted pyrazinones represent a novel class of allosteric modulators of GABAA receptors, with their binding site probably located between the alpha and beta subunits.
Similar articles
-
Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.Mol Pharmacol. 1996 Nov;50(5):1364-75. Mol Pharmacol. 1996. PMID: 8913369
-
Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.Mol Pharmacol. 1993 Oct;44(4):866-70. Mol Pharmacol. 1993. PMID: 7901754
-
U-89843A is a novel allosteric modulator of gamma-aminobutyric acidA receptors.J Pharmacol Exp Ther. 1995 Dec;275(3):1390-5. J Pharmacol Exp Ther. 1995. PMID: 8531107
-
From ion currents to genomic analysis: recent advances in GABAA receptor research.Synapse. 1995 Nov;21(3):189-274. doi: 10.1002/syn.890210302. Synapse. 1995. PMID: 8578436 Review.
-
[GABA(A) benzodiazepine receptors and epilepsy].Wien Klin Wochenschr. 1990 Mar 30;102(7):197-201. Wien Klin Wochenschr. 1990. PMID: 2160756 Review. German.
Cited by
-
Characterization of U-97775 as a GABAA receptor ligand of dual functionality in cloned rat GABAA receptor subtypes.Br J Pharmacol. 1995 May;115(1):19-24. doi: 10.1111/j.1476-5381.1995.tb16314.x. Br J Pharmacol. 1995. PMID: 7647975 Free PMC article.
-
Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.Br J Pharmacol. 1995 Mar;114(5):1040-4. doi: 10.1111/j.1476-5381.1995.tb13310.x. Br J Pharmacol. 1995. PMID: 7780638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials